Profil
William D.
Welch is Vice President of Development for HemaQuest Pharmaceuticals, Inc. Prior to joining HemaQuest Pharmaceuticals, he was Senior Director of Therapeutic Development for ICOS Corp.
from 2002 to 2007, Therapeutic Group Leader of Oncology for Amgen, Inc. from 1997 to 2002 and Director of Laboratory Operations for MetPath Laboratories.
Dr. Welch founded CRO and Western Medical Clinical Laboratories, Inc. and served as President.
He began his career at the University of Texas Health Science Center as an Assistant Professor in the Department of Pathology.
He has more than 20 years of experience in drug development.
Dr. Welch received a PhD in Microbiology and Immunology from the University of California, Los Angeles.
Anciens postes connus de William D. Welch
| Sociétés | Poste | Fin |
|---|---|---|
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Corporate Officer/Principal | 01/01/2007 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2002 |
| MetPath Laboratories | Corporate Officer/Principal | - |
Formation de William D. Welch
| University of California, Berkeley | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
| MetPath Laboratories |
